Prediction of preterm delivery using plasma corticotrophin-releasing hormone and other biochemical variables

Annals of Medicine

Volumn 34, Issue 1, 2002, Pages 28-36

  McGrath, Shaun ^a   Smith, Roger ^a  

^a JOHN HUNTER HOSPITAL   (Australia)

Author keywords

Biochemical marker; Corticotrophin releasing hormone; Prediction; Preterm delivery

Indexed keywords

ACTIVIN A; ALPHA FETOPROTEIN; ANDROGEN; BIOCHEMICAL MARKER; CHORIONIC GONADOTROPIN; CORTICOTROPIN; CORTICOTROPIN RELEASING FACTOR; CYTOKINE; ESTRIOL; FIBRONECTIN; GELATINASE B; GRANULOCYTE COLONY STIMULATING FACTOR; RELAXIN; TISSUE INHIBITOR OF METALLOPROTEINASE 1;

CHILDBIRTH; DISEASE MARKER; HIGH RISK POPULATION; HUMAN; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; PATHOPHYSIOLOGY; PREDICTION; PREMATURE LABOR; PRIORITY JOURNAL; REVIEW;

ADRENOCORTICOTROPIC HORMONE; BIOLOGICAL MARKERS; CORTICOTROPIN-RELEASING HORMONE; FEMALE; FETAL BLOOD; HUMANS; OBSTETRIC LABOR, PREMATURE; PLACENTA DISEASES; PREDICTIVE VALUE OF TESTS; PREGNANCY; PREGNANCY, HIGH-RISK; SENSITIVITY AND SPECIFICITY;

EID: 0036235112     PISSN: 07853890     EISSN: None     Source Type: Journal    
DOI: 10.1080/078538902317338616     Document Type: Review

References (79)

1. System for predicting spontaneous preterm birth
2. The preterm prediction study: A clinical risk assessment system
3. Endocrine and paracrine regulation of birth at term and preterm
4. Tocolytics for preterm labor: A systematic review
5. Corticotropin-releasing hormone in chimpanzee and gorilla pregnancies
6. Markers of risk for preterm delivery
7. Prevention of preterm birth
8. Corticotropin-releasing hormone in amniotic fluid during gestation and labor and in relation to fetal lung maturation
9. Characterization of a 41-residue ovine hypothalamic peptide that stimulates secretion of corticotropin and beta-endorphin
10. Immunoreactive corticotropin-releasing factor is present in human maternal plasma during the third trimester of pregnancy
11. High levels of corticotropin-releasing hormone immunoactivity in maternal and fetal plasma during pregnancy
12. Plasma corticotropin-releasing hormone concentrations during pregnancy and parturition
13. Immunoreactive corticotropin-releasing hormone in human plasma during pregnancy, labor, and delivery
14. Glucocorticoid stimulates expression of corticotropin-releasing hormone gene in human placenta
15. Steroids modulate corticotropin-releasing hormone production in human fetal membranes and placenta
16. Corticotrophin-releasing factor-like immunoreactivity and bioactivity of human fetal and adult hypothalami
17. Corticotropin-releasing hormone directly and preferentially stimulates dehydroepiandrosterone sulfate secretion by human fetal adrenal cortical cells
18. Corticotropin-releasing hormone stimulates steroidogenesis in cultured human adrenal cells
19. Biologically active corticotropin-releasing hormone in maternal and fetal plasma during pregnancy
20. Immunoreactive corticotropin-releasing hormone, adrenocorticotropin and cortisol in human plasma during pregnancy and delivery and postpartum
21. Corticotrophin releasing hormone levels in human plasma and amniotic fluid during gestation
22. Maternal plasma corticotrophin-releasing hormone-elevated in preterm labour but unaffected by indomethacin or nylidrin
23. Elevated maternal plasma corticotropin-releasing hormone levels in pregnancies complicated by preterm labor
24. Maternal corticotropin-releasing hormone is increased with impending preterm birth
25. Corticotropin-releasing hormone, corticotropin-releasing hormone-binding protein, and activin A in maternal serum: Prediction of preterm delivery and response to glucocorticoids in women with symptoms of preterm labor
26. Prediction of preterm delivery by fetal fibronectin: A meta-analysis
27. A placental clock controlling the length of human pregnancy
28. Corticotropin-releasing factor and its binding protein: Maternal serum levels in term and preterm deliveries
29. Maternal corticotropin-releasing hormone levels in the early third trimester predict length of gestation in human pregnancy
30. Elevated mid-trimester maternal corticotrophin-releasing hormone levels in pregnancies that delivered before 34 weeks
31. Predicting risk of preterm delivery by second-trimester measurement of maternal plasma corticotropin-releasing hormone and alpha-fetoprotein concentrations
32. Maternal plasma corticotropin-releasing hormone associated with stress at 20 weeks' gestation in pregnancies ending in preterm delivery
33. Preterm birth: Associated neuroendocrine, medical, and behavioral risk factors
34. The utility of plasma CRH as a predictor of premature labour and delivery
35. The role of cortisol in preparing the fetus for birth
36. Corticotropin-releasing hormone and related pituitary-adrenal axis hormones in fetal and maternal blood during the second half of pregnancy
37. Plasma corticotrophin-releasing factor (CRF) in abnormal pregnancy
38. Elevated levels of umbilical cord plasma corticotropin-releasing hormone in growth-retarded fetuses
39. Abnormal umbilical artery Doppler waveforms and cord blood corticotropin-releasing hormone
40. Corticotropin-releasing hormone and cortisol in cord plasma in relation to gestational age, labor, and fetal distress
41. Corticotropin-releasing hormone-induced vasodilatation in the human fetal placental circulation
42. Glucocorticoid regulation of human and ovine parturition: The relationship between fetal hypothalamic-pituitary-adrenal axis activation and intrauterine prostaglandin production
43. Peptide signaling in human placenta and membranes: Autocrine, paracrine, and endocrine mechanisms
44. Placental estrogen biosynthesis during human pregnancy
45. Saliva oestriol, oestradiol, oestrone and progesterone levels in pregnancy: Spontaneous labour at term is preceded by a rise in the saliva oestriol:progesterone ratio
46. Salivary estriol as risk assessment for preterm labor: A prospective trial
47. Increasing saliva (free) oestriol to progesterone ratio in late pregnancy: A role for oestriol in initiating spontaneous labour in man?
48. Increased saliva oestriol to progesterone ratio before preterm delivery: A possible predictor for preterm labor?
49. Lack of normal increase in saliva estriol/progesterone ratio in women with labor induced at 42 weeks' gestation
50. Actions of placental and fetal adrenal steroid hormones in primate pregnancy
51. Oestriol and oestradiol increase cell to cell communication and connexin43 protein expression in human myometrium
52. Results of a prospective, blinded, multicentre trial of salivary estriol for risk of preterm labour and delivery
53. Accuracy of salivary estriol testing compared to traditional risk factor assessment in predicting preterm birth
54. Inhibin, activin and follistatin in the human placenta - A new family of regulatory proteins
55. Inhibin and activin in human fetal membranes: Evidence for a local effect on prostaglandin release
56. Feto-placental hypoxemia regulates the release of fetal activin A and prostaglandin E(2)
57. Abnormal concentration of maternal serum activin-A in gestational diseases
58. Activin A and inhibin A as possible endocrine markers for pre-eclampsia
59. Comparison of maternal serum total activm A and inhibin A in normal, preeclamptic, and non-proteinuric gestationally hypertensive pregnancies
60. Increased maternal serum activin A but not follistatin levels in pregnant women with hypertensive disorders
61. Serum inhibin A and activin A are elevated prior to the onset of pre-eclampsia
62. Maternal serum total activin A and follistatin in pregnancy and parturition
63. Cytokines and the initiation of parturition
64. Elevated plasma interleukin 6: A biochemical marker of human preterm labour
65. Maternal serum interleukin-6 during pregnancy and during term and preterm labor
66. Value of the maternal interleukin 6 level for determination of histologic chorioamnionitis in preterm delivery
67. Fetal but not maternal serum cytokine levels correlate with histologic acute placental inflammation
68. Maternal serum interleukin-6 concentrations in patients with preterm premature rupture of membranes and evidence of infection
69. Maternal serum interleukin-6 concentration as a marker for impending preterm delivery
70. The preterm prediction study: Granulocyte colony-stimulating factor and spontaneous preterm birth
71. Biochemical events in cervical ripening dilatation during pregnancy and parturition
72. Matrix metalloproteinases-9 in preterm and term human parturition
73. Matrix metalloproteinase 9 activity in urine of patients at risk for premature delivery
74. The preterm prediction study: Patterns of cervicovaginal fetal fibronectin as predictors of spontaneous preterm delivery
75. Relaxin and the cervix
76. Serum relaxin as a potential marker for preterm labour
77. Elevated first-trimester serum relaxin concentrations in pregnant women following ovarian stimulation predict prematurity risk and preterm delivery
78. Second-trimester maternal serum marker screening: Maternal serum alpha-fetoprotein, beta-human chorionic gonadotropin, estriol, and their various combinations as predictors of pregnancy outcome
79. Toward a multiple marker test for spontaneous preterm birth (SPB) (abs)